Fidelity Investments’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
374,481
+294,083
+366% +$931K ﹤0.01% 2870
2025
Q4
$297K Buy
80,398
+17,075
+27% +$55.2K ﹤0.01% 3277
2025
Q3
$168K Buy
63,323
+3,291
+5% +$6.37K ﹤0.01% 3441
2025
Q2
$59.1K Sell
60,032
-13,138
-18% -$13.2K ﹤0.01% 3815
2025
Q1
$105K Sell
73,170
-38,091
-34% -$70.2K ﹤0.01% 3533
2024
Q4
$245K Buy
111,261
+40,097
+56% +$93.5K ﹤0.01% 3189
2024
Q3
$117K Sell
71,164
-5,917
-8% -$11.9K ﹤0.01% 3400
2024
Q2
$171K Sell
77,081
-28,090
-27% -$66.1K ﹤0.01% 3082
2024
Q1
$282K Sell
105,171
-171,675
-62% -$417K ﹤0.01% 2910
2023
Q4
$828K Buy
276,846
+23,785
+9% +$30.9K ﹤0.01% 2526
2023
Q3
$248K Buy
253,061
+12,580
+5% +$18.2K ﹤0.01% 2822
2023
Q2
$334K Buy
240,481
+148,439
+161% +$207K ﹤0.01% 2788
2023
Q1
$146K Sell
92,042
-2,932
-3% -$15.1K ﹤0.01% 3076
2022
Q4
$592K Buy
94,974
+86,660
+1,042% +$620K ﹤0.01% 2667
2022
Q3
$55K Sell
8,314
-355
-4% -$2.44K ﹤0.01% 3448
2022
Q2
$55K Buy
8,669
+2,003
+30% +$11.4K ﹤0.01% 3527
2022
Q1
$31K Buy
+6,666
New +$28.6K ﹤0.01% 3854
2021
Q1
Sell
-127,199
Closed -$3.31M 4117
2020
Q4
$3.31M Sell
127,199
-1
-0% -$30 ﹤0.01% 2289
2020
Q3
$4.73M Sell
127,200
-11,240
-8% -$445K ﹤0.01% 2091
2020
Q2
$7.1M Sell
138,440
-69,089
-33% -$2.89M ﹤0.01% 1935
2020
Q1
$6.54M Buy
207,529
+1,665
+0.8% +$87.9K ﹤0.01% 1834
2019
Q4
$12.3M Sell
205,864
-16,389
-7% -$737K ﹤0.01% 1779
2019
Q3
$8.15M Sell
222,253
-50,376
-18% -$2M ﹤0.01% 1900
2019
Q2
$12.7M Sell
272,629
-306,607
-53% -$14.4M ﹤0.01% 1804
2019
Q1
$23.3M Sell
579,236
-160,053
-22% -$7.18M ﹤0.01% 1541
2018
Q4
$34M Buy
739,289
+225,205
+44% +$10.9M ﹤0.01% 1330
2018
Q3
$22.8M Sell
514,084
-408,895
-44% -$18.8M ﹤0.01% 1624
2018
Q2
$36.2M Sell
922,979
-802,190
-46% -$40.5M ﹤0.01% 1436
2018
Q1
$125M Buy
1,725,169
+470,181
+37% +$34.5M 0.01% 885
2017
Q4
$82.6M Sell
1,254,988
-87,900
-7% -$4.73M 0.01% 1082
2017
Q3
$67.3M Buy
1,342,888
+4,300
+0.3% +$207K 0.01% 1166
2017
Q2
$62M Buy
1,338,588
+30,000
+2% +$1.1M 0.01% 1199
2017
Q1
$46.2M Buy
1,308,588
+542,579
+71% +$12.4M 0.01% 1335
2016
Q4
$9.59M Hold
766,009
﹤0.01% 1989
2016
Q3
$10.6M Sell
766,009
-302,941
-28% -$3.43M ﹤0.01% 1967
2016
Q2
$10.6M Sell
1,068,950
-106,800
-9% -$1.77M ﹤0.01% 1936
2016
Q1
$19.9M Sell
1,175,750
-704,500
-37% -$11.3M ﹤0.01% 1665
2015
Q4
$41.9M Sell
1,880,250
-656,021
-26% -$16.6M 0.01% 1330
2015
Q3
$59.8M Buy
2,536,271
+327,039
+15% +$20.5M 0.01% 1166
2015
Q2
$181M Buy
2,209,232
+22,900
+1% +$2.24M 0.02% 752
2015
Q1
$202M Buy
2,186,332
+785,058
+56% +$50.7M 0.03% 688
2014
Q4
$56.7M Buy
1,401,274
+1,317,474
+1,572% +$40.3M 0.01% 1271
2014
Q3
$2.05M Hold
83,800
﹤0.01% 2422
2014
Q2
$1.33M Sell
83,800
-5,300
-6% -$76.6K ﹤0.01% 2467
2014
Q1
$1.35M Hold
89,100
﹤0.01% 2433
2013
Q4
$1.22M Sell
89,100
-403,900
-82% -$5.88M ﹤0.01% 2421
2013
Q3
$9.3M Buy
+493,000
New +$8.28M ﹤0.01% 1968

Other funds holding ESPR